Craig S. Gibbs
Chief Executive Officer at Asher Biotherapeutics, Inc.
Net worth: - $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brett Pletcher | M | 56 | 19 years | |
| Andrew Dickinson | M | 54 | 4 years | |
| Ian Clark | M | 62 |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | 5 years |
| Susan Windham-Bannister | M | 74 | 5 years | |
| Ivana Djuretic | M | - |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | 5 years |
| Andy Yeung | M | - |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | 5 years |
| Jeffrey Tong | M | 48 |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | - |
| Linda Higgins | M | 62 | 14 years | |
| Elaine Sun | F | 53 |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | 1 years |
| Reid Huber | M | 52 |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | 3 years |
| Christina Carlson | F | - | 4 years | |
| Hasan Jafri | M | 57 | 4 years | |
| Bob Deresiewicz | M | - |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | 2 years |
| Robert Cook | M | 65 | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregg Alton | M | 58 | 20 years | |
| Andrew Hindman | M | 51 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | 14 years |
| Irving L. Weissman | M | 84 | 6 years | |
| Mark Perry | M | 68 | 10 years | |
| Fred Kurland | M | 74 | 7 years | |
| Ravindra Majeti | M | 51 | 6 years | |
| Mark McCamish | M | 72 | 3 years | |
| Jeff Bird | M | 63 | 18 years | |
| Linda Fitzpatrick | F | 67 | 10 years | |
| Jonathan MacQuitty | M | 71 | 2 years | |
| David Dornan | M | 46 | 5 years | |
| Gordon Earle Moore | M | 95 | 17 years | |
| Per Wold-Olsen | M | 76 | - | |
| Michael Nazak | M | 66 | 3 years | |
| Andrew Cheng | M | 57 | 19 years | |
| Kristine Ball | M | 52 | 2 years | |
| John McHutchison | M | 66 | 9 years | |
| Graeme J. Moyle | M | 60 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
| Shawn Lu | M | 56 | - | |
| Richard Whitley | M | 78 | 13 years | |
| Kevin Lofton | M | 69 | 15 years | |
| Nicholas G. Moore | M | 82 | - | |
| Dennis J. Henner | M | 72 | 5 years | |
| Carla A. Hills | F | 90 | - | |
| John Francis Cogan | M | 76 | - | |
| Jeffrey Cooper | M | 68 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
| James M. Denny | M | 91 | 17 years | |
| Paul A. Berg | M | 97 | 13 years | |
| Robin Washington | F | 60 | 11 years | |
| Gayle Edlund Wilson | F | 81 | - | |
| Chris Schaepe | M | 61 | 4 years | |
| Robert Ruffolo | M | 74 | 7 years | |
| John Madigan | M | 86 | 12 years | |
| Michael Bigham | M | 66 | 8 years | |
| David Johnson | M | 55 | 15 years | |
| Kitty Yale | F | 52 | 17 years | |
| Kenneth Lynard | M | 56 | 4 years | |
| Chris Takimoto | M | 65 | 4 years | |
| Elizabeth Bhatt | F | 56 | 11 years | |
| Michael S. Louie | M | - | 29 years | |
| Susannah Cantrell | M | - | 8 years | |
| Rajesh Krishnan | M | 51 | 5 years | |
| Roger Dansey | M | 68 | 1 years | |
| Hunter Gillies | M | 58 | 5 years | |
| Pawel Trawkowski | M | - | - | |
| Stephen Cheng | M | - | 7 years | |
| Thomas Russo | M | 52 | 7 years | |
| Dana Pizzuti | M | 69 | 10 years | |
| Erin Quirk | M | 53 | 8 years | |
| Lee Song | F | 49 | 14 years | |
| Christophe Quéva | M | 57 | 3 years | |
| Nicole White | F | 44 | 6 years | |
| Lian Hong Xu | M | 58 | 20 years | |
| Monica Viziano | M | 57 | 18 years | |
| Brian P. Kearney | M | 52 | 21 years | |
| Arvinder Dhalla | M | - | 6 years | |
| Marni Kottle | F | - | 8 years | |
| Matthew Lang | M | 48 | 8 years | |
| Jennifer A. Troia | F | - | 2 years | |
| Wayne Godfrey | M | 63 | 3 years | |
| Dee Datta | M | - | 1 years | |
| Tai Yin Yang | M | 70 | 29 years | |
| Kenneth F. Boehm | M | - | 11 years | |
| Ann Rhoads | F | 58 | 2 years | |
| J. William Freytag | M | 72 | 1 years | |
| Kevin B. Young | M | 66 | 10 years | |
| Michael W. Aguiar | M | 57 | - | |
| Mark D. Matteucci | M | 70 | 11 years | |
| Susan T. Hubbard | F | - | 23 years | |
| Kristen M. Metza | F | 64 | - | |
| Melissa Yeager | F | - | 8 years | |
| Paul M. Mendelman | M | 76 | 1 years | |
| Paul Carter | M | 63 | 10 years | |
| Sung Lee | M | 53 | 14 years | |
| John Latham | M | 64 | 5 years | |
| Philip T. Sager | M | 68 | 1 years | |
| Michael Hongjie Lan | M | 56 | - | |
| Wolfgang Dummer | M | 58 | 1 years | |
| Katie L. Watson | F | - | 16 years | |
| Noreen Henig | M | 59 | 6 years | |
| Smital Shah | F | 48 | 2 years | |
| Andrew Aristidou | M | - | - | |
| Tse Li Yang | F | 51 | 12 years | |
| Charles Winter | M | - | 4 years | |
| Ashraf Amanullah | M | 56 | 4 years | |
| Aaron Brinkworth | M | - | 22 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Craig S. Gibbs
- Personal Network
